Celiac Disease Market by Therapy Type (First Line of Treatment and Second Line of Treatment) - Global Industry Analysis and Forecast to 2025

Published On : August 2018 Pages : 170 Category: Pharmaceuticals Report Code : HC081196

Industry Outlook and Trend Analysis

The Celiac Disease Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Celiac disease is a hereditary, auto-immune disease that influences the small intestine when consumed gluten. Celiac sicknesses may add to different infections and clutters, for example, neurological disorders, low bone density, certain cancers, and infertility. There are no medications accessible that can treat celiac diseases. There are couple of anti-inflammatory and immunosuppressant drugs and wholesome supplements that are utilized as off-label treatment in celiac disease. All these off-label treatments are considered as second-line of treatment.

Drivers and Restraints

Development in the predominance of celiac diseases is the main consideration that drives the development of the celiac disease market. Also, the reliance on gluten rich food and patterns of ready-to-use packaged food have expanded the interest for the celiac disease market. Besides, ascend in the expenditure for healthcare and increment in interests in celiac disease awareness programs by governments and private associations, for example, National Program for the Detection and Control of Celiac Disease are foreseen to support the market development. Nonetheless, stringent government controls for the approval of drugs obstruct the development.

Market Segmentation

The Celiac Disease Market is segmented on the basis of therapy type into First Line of Treatment and Second Line of Treatment. In the first line of treatment the patients are commonly taken off any kind of gluten that is being consumed which is vital for the treatment. The awareness of the disease has increased substantially over the recent years and is one of the major factors boosting the development of the market.

Regional Outlook and Trend Analysis

North America rules the worldwide market for celiac drugs because of rising occurrence of celiac malady and few treatment alternatives in the locale. Asia is anticipated to demonstrate high development rates in the following years in worldwide celiac disease market, with China and India being the quickest developing markets in the Asia-Pacific locale. The main driving factors for the celiac disease market in emerging nations are the expansive pool of patients, expanding awareness about the illness, and rising government subsidizing in the district.

Competitive Insights

The leading players in the market are Merck & Co, ImmusanT Inc, BioLineRx, Immunomedics Inc, Johnson & Johnson, Bristol-Myers Squibb, Roche Holding AG, Novartis, Pfizer and Innovate. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

The Celiac Disease Market is segmented as follows-

By Therapy Type:

  • First Line of Treatment
  • Second Line of Treatment

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Some of the key questions answered by the report are:

  • What was the market size in 2014 and forecast from 2015 to 2025?
  • What will be the industry market growth from 2015 to 2025?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Celiac Disease Market, By Therapy Type, Estimates and Forecast, 2014-2025($Billion)

o    First Line of Treatment

o    Second Line of Treatment

·         Celiac Disease Market, By Region, Estimates and Forecast, 2014-2025($Billion)

o    North America

§  North America Celiac Disease Market, By Country

o    U.S. Celiac Disease Market

o    Canada Celiac Disease Market

o    Mexico Celiac Disease Market

o    Europe

§  Europe Celiac Disease Market, By Country

o    Germany Celiac Disease Market

o    UK Celiac Disease Market

o    France Celiac Disease Market

o    Russia Celiac Disease Market

o    Italy Celiac Disease Market

o    Rest of Europe Celiac Disease Market

o    Asia-Pacific

§  Asia-Pacific Celiac Disease Market, By Country

o    China Celiac Disease Market

o    Japan Celiac Disease Market

o    South Korea Celiac Disease Market

o    India Celiac Disease Market

o    Southeast Asia Celiac Disease Market

o    Rest of Asia-Pacific Celiac Disease Market

o    South America

§  South America Celiac Disease Market

o    Brazil Celiac Disease Market

o    Argentina Celiac Disease Market

o    Columbia Celiac Disease Market

o    Rest of South America Celiac Disease Market

o    Middle East and Africa

§  Middle East and Africa Celiac Disease Market

o    Saudi Arabia Celiac Disease Market

o    UAE Celiac Disease Market

o    Egypt Celiac Disease Market

o    Nigeria Celiac Disease Market

o    South Africa Celiac Disease Market

o    Rest of MEA Celiac Disease Market

Table of Contents

1.       Introduction

1.1.       Report Description

2.       Executive Summary

2.1.       Key Highlights

3.       Market Overview

3.1.       Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.       Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.2.3.1.    Emerging Markets to Offer Lucrative Growth Opportunities

4.       Market Analysis by Regions

4.1.       North America (United States, Canada and Mexico)

4.1.1.  United States Market States and Outlook (2014-2025)

4.1.2.  Canada Market States and Outlook (2014-2025)

4.1.3.  Mexico Market States and Outlook (2014-2025)

4.2.       Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market States and Outlook (2014-2025)

4.2.2.  France Market States and Outlook (2014-2025)

4.2.3.  UK Market States and Outlook (2014-2025)

4.2.4.  Russia Market States and Outlook (2014-2025)

4.2.5.  Italy Market States and Outlook (2014-2025)

4.2.6.  Rest of Europe Market States and Outlook (2014-2025)

4.3.       Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market States and Outlook (2014-2025)

4.3.2.  Japan Market States and Outlook (2014-2025)

4.3.3.  Korea Market States and Outlook (2014-2025)

4.3.4.  India Market States and Outlook (2014-2025)

4.3.5.  Rest of Asia-Pacific Market States and Outlook (2014-2025)

4.4.       South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market States and Outlook (2014-2025)

4.4.2.  Argentina Market States and Outlook (2014-2025)

4.4.3.  Columbia Market States and Outlook (2014-2025)

4.4.4.  Rest of South America Market States and Outlook (2014-2025)

4.5.       Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market States and Outlook (2014-2025)

4.5.2.  UAE Market States and Outlook (2014-2025)

4.5.3.  Egypt Market States and Outlook (2014-2025)

4.5.4.  Nigeria Market States and Outlook (2014-2025)

4.5.5.  South Africa Market States and Outlook (2014-2025)

4.5.6.  Rest of MEA Market States and Outlook (2014-2025)

5.       Celiac Disease Market, By Therapy Type

5.1.       Introduction

5.2.       Global Celiac Disease Revenue and Market Share By Therapy Type (2014-2018)

5.2.1.  Global Celiac Disease Revenue and Revenue Share By Therapy Type (2014-2018)

5.3.       First Line of Treatment

5.3.1.  Global New Construction Revenue and Growth Rate (2014-2018)

5.4.       Second Line of Treatment

5.4.1.  Global Renovation Revenue and Growth Rate (2014-2018)

6.       Celiac Disease Market, By Region

6.1.       Introduction

6.2.       Global Celiac Disease Revenue and Market Share by Regions

6.2.1.  Global Celiac Disease Revenue by Regions (2014-2018)

6.3.       North America Celiac Disease by Countries

6.3.1.  North America Celiac Disease Revenue and Growth Rate (2014-2018)

6.3.2.  North America Celiac Disease Revenue (Million USD) by Countries (2014-2018)

6.3.3.  U.S.

6.3.3.1.    United States Celiac Disease Revenue (Millions USD) and Growth Rate (2014-2018)

6.3.4.  Canada

6.3.4.1.    Canada Celiac Disease Revenue (Millions USD) and Growth Rate (2014-2018)

6.3.5.  Mexico

6.3.5.1.    Mexico Celiac Disease Revenue (Millions USD) and Growth Rate (2014-2018)

6.4.       Europe Celiac Disease by Countries

6.4.1.  Europe Celiac Disease Revenue and Growth Rate (2014-2018)

6.4.2.  Europe Celiac Disease Revenue (Million USD) by Countries (2014-2018)

6.4.3.  Germany

6.4.3.1.    Germany Celiac Disease Revenue (Millions USD) and Growth Rate (2014-2018)

6.4.4.  UK

6.4.4.1.    UK Celiac Disease Revenue (Millions USD) and Growth Rate (2014-2018)

6.4.5.  France

6.4.5.1.    France Celiac Disease Revenue (Millions USD) and Growth Rate (2014-2018)

6.4.6.  Russia

6.4.6.1.    Russia Celiac Disease Revenue (Millions USD) and Growth Rate (2014-2018)

6.4.7.  Italy

6.4.7.1.    Italy Celiac Disease Revenue (Millions USD) and Growth Rate (2014-2018)

6.4.8.  Rest of Europe

6.4.8.1.    Rest of Europe Celiac Disease Revenue (Millions USD) and Growth Rate (2014-2018)

6.5.       Asia-Pacific

6.5.1.  Asia-Pacific Celiac Disease Revenue and Growth Rate (2014-2018)

6.5.2.  Asia-Pacific Celiac Disease Revenue (Million USD) by Countries (2014-2018)

6.5.3.  China

6.5.3.1.    China Celiac Disease Revenue (Millions USD) and Growth Rate (2014-2018)

6.5.4.  Japan

6.5.4.1.    Japan Celiac Disease Revenue (Millions USD) and Growth Rate (2014-2018)

6.5.5.  Korea

6.5.5.1.    Korea Celiac Disease Revenue (Millions USD) and Growth Rate (2014-2018)

6.5.6.  India

6.5.6.1.    India Celiac Disease Revenue (Millions USD) and Growth Rate (2014-2018)

6.5.7.  Southeast Asia

6.5.7.1.    Southeast Asia Celiac Disease Revenue (Millions USD) and Growth Rate (2014-2018)

6.5.8.  Rest of Asia-Pacific

6.5.8.1.    Rest of Asia-Pacific Celiac Disease Revenue (Millions USD) and Growth Rate (2014-2018)

6.6.       South America

6.6.1.  South America Celiac Disease Revenue and Growth Rate (2014-2018)

6.6.2.  South America Celiac Disease Revenue (Million USD) by Countries (2014-2018)

6.6.3.  Brazil

6.6.3.1.    Brazil Celiac Disease Revenue (Millions USD) and Growth Rate (2014-2018)

6.6.4.  Argentina

6.6.4.1.    Argentina Celiac Disease Revenue (Millions USD) and Growth Rate (2014-2018)

6.6.5.  Columbia

6.6.5.1.    Columbia Celiac Disease Revenue (Millions USD) and Growth Rate (2014-2018)

6.6.6.  Rest of South America

6.6.6.1.    Rest of South America Celiac Disease Revenue (Millions USD) and Growth Rate (2014-2018)

6.7.       Middle East and Africa

6.7.1.  Middle East and Africa Celiac Disease Revenue and Growth Rate (2014-2018)

6.7.2.  Middle East and Africa Celiac Disease Revenue (Million USD) by Countries (2014-2018)

6.7.3.  Saudi Arabia

6.7.3.1.    Saudi Arabia Celiac Disease Revenue (Millions USD) and Growth Rate (2014-2018)

6.7.4.  United Arab Emirates

6.7.4.1.    United Arab Emirates Celiac Disease Revenue (Millions USD) and Growth Rate (2014-2018)

6.7.5.  Egypt

6.7.5.1.    Egypt Celiac Disease Revenue (Millions USD) and Growth Rate (2014-2018)

6.7.6.  Nigeria

6.7.6.1.    Nigeria Celiac Disease Revenue (Millions USD) and Growth Rate (2014-2018)

6.7.7.  South Africa

6.7.7.1.    South Africa Celiac Disease Revenue (Millions USD) and Growth Rate (2014-2018)

6.7.8.  Rest of Middle East and Africa

6.7.8.1.    Rest of Middle East and Africa Celiac Disease Revenue (Millions USD) and Growth Rate (2014-2018)

7.       Company Profiles

7.1.       Merck & Co., Inc.

7.1.1.  Business Overview

7.1.2.  Product Portfolio

7.1.3.  Strategic Developments

7.1.4.   Revenue and Market Share

7.2.       Innovate Biopharmaceuticals

7.2.1.  Business Overview

7.2.2.  Product Portfolio

7.2.3.  Strategic Developments

7.2.4.   Revenue and Market Share

7.3.       F. Hoffmann-La Roche

7.3.1.  Business Overview

7.3.2.  Product Portfolio

7.3.3.  Strategic Developments

7.3.4.   Revenue and Market Share

7.4.       Johnson & Johnson         

7.4.1.  Business Overview

7.4.2.  Product Portfolio

7.4.3.  Strategic Developments

7.4.4.   Revenue and Market Share

7.5.       Novartis AG       

7.5.1.  Business Overview

7.5.2.  Product Portfolio

7.5.3.  Strategic Developments

7.5.4.   Revenue and Market Share

7.6.       Pfizer Inc.

7.6.1.  Business Overview

7.6.2.  Product Portfolio

7.6.3.  Strategic Developments

7.6.4.   Revenue and Market Share

7.7.        BiolineRx Ltd.

7.7.1.  Business Overview

7.7.2.  Product Portfolio

7.7.3.  Strategic Developments

7.7.4.   Revenue and Market Share

7.8.       ImmusanT, Inc.

7.8.1.  Business Overview

7.8.2.  Product Portfolio

7.8.3.  Strategic Developments

7.8.4.   Revenue and Market Share

7.9.       Immunomedics, Inc.

7.9.1.  Business Overview

7.9.2.  Product Portfolio

7.9.3.  Strategic Developments

7.9.4.   Revenue and Market Share

7.10.    Bristol-Myers Squibb Company

7.10.1.      Business Overview

7.10.2.      Product Portfolio

7.10.3.      Strategic Developments

7.10.4.       Revenue and Market Share

8.       Global Celiac Disease Market Competition, by Manufacturer

8.1.       Global Celiac Disease Revenue and Market Share by Manufacturer (2016-2017)

8.2.       Global Celiac Disease Revenue and Market Share by Manufacturer (2016-2017)

8.3.       Global Celiac Disease Price by Manufacturer (2016-2017)

8.4.       Top 5 Celiac Disease Manufacturer Market Share

8.5.       Market Competition Trend

9.       Celiac Disease Market Forecast (2018-2025)

9.1.       Global Celiac Disease Revenue (Millions USD) and Growth Rate (2018-2025)

9.2.       Celiac Disease Market Forecast by Regions (2018-2025)

9.2.1.  North America Celiac Disease Market Forecast (2018-2025)

9.2.1.1.    United States Celiac Disease Market Forecast (2018-2025)

9.2.1.2.    Canada Celiac Disease Market Forecast (2018-2025)

9.2.1.3.    Mexico Celiac Disease Market Forecast (2018-2025)

9.2.2.  Europe Celiac Disease Market Forecast (2018-2025)

9.2.2.1.    Germany Celiac Disease Market Forecast (2018-2025)

9.2.2.2.    United Kingdom Celiac Diseases Market Forecast (2018-2025)

9.2.2.3.    France Celiac Disease Market Forecast (2018-2025)

9.2.2.4.    Russia Celiac Disease Market Forecast (2018-2025)

9.2.2.5.    Italy Celiac Disease Market Forecast (2018-2025)

9.2.2.6.    Rest of the Europe Celiac Disease Market Forecast (2018-2025)

9.2.3.  Asia-Pacific Celiac Disease Market Forecast (2018-2025)

9.2.3.1.    China Celiac Disease Market Forecast (2018-2025)

9.2.3.2.    Japan Celiac Disease Market Forecast (2018-2025)

9.2.3.3.    Korea Celiac Disease Market Forecast (2018-2025)

9.2.3.4.    India Celiac Disease Market Forecast (2018-2025)

9.2.3.5.    Southeast Asia Celiac Disease Market Forecast (2018-2025)

9.2.3.6.    Rest of Asia-Pacific Celiac Disease Market Forecast (2018-2025)

9.2.4.  South America Celiac Disease Market Forecast (2018-2025)

9.2.4.1.    Brazil Celiac Disease Market Forecast (2018-2025)

9.2.4.2.    Argentina Celiac Disease Market Forecast (2018-2025)

9.2.4.3.    Columbia Celiac Disease Market Forecast (2018-2025)

9.2.4.4.    Rest of South America Celiac Disease Market Forecast (2018-2025)

9.2.5.  Middle East and Africa Celiac Disease Market Forecast (2018-2025)

9.2.5.1.    Saudi Arabia Celiac Disease Market Forecast (2018-2025)

9.2.5.2.    UAE Celiac Disease Market Forecast (2018-2025)

9.2.5.3.    Egypt Celiac Disease Market Forecast (2018-2025)

9.2.5.4.    Nigeria Celiac Disease Market Forecast (2018-2025)

9.2.5.5.    South Africa Celiac Disease Market Forecast (2018-2025)

9.2.5.6.    Rest of MEA Celiac Disease Market Forecast (2018-2025)

9.3.       Celiac Disease Market Forecast by Therapy Type (2018-2025)

9.3.1.  Global Celiac Disease Revenue Forecast by Therapy Type (2018-2025)

9.3.2.  Global Celiac Disease Revenue Market Share Forecast by Therapy Type (2018-2025)

10.   Research Methodology

10.1.1.      Secondary Research

10.1.2.      Primary Research


List of Tables

*You can glance through the list of Tables and Figures when you view the sample copy of Celiac Disease Market.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*